Men whose genomes contain a polymorphism in the gene for manganese superoxide dismutase (MnSOD) that results in an alanine (A) instead of a valine (V) at the corresponding codon 16 exhibit a 10-fold increase in aggressive prostate cancer risk when those in the lowest tertile of anti-oxidant intake are compared to those in the highest. The MnSOD encoded by the A-expressing allele partitions more efficiently to the mitochondria where it may promote cancer development by increasing the production of H2O2 from superoxide or due to its inherent ability to function as a peroxidase to generate oxidative damage. Increased cancer risk among MnSOD(A) men is also associated with the presence of a polymorphism in the anti-oxidant selenium-dependent glutathione peroxidase-1 (GPx-1) protein and the selenium transport protein SEPP1. Based on these human epidemiological data, it is proposed that MnSOD exists at the center of an axis of a small number of anti-oxidant molecules that together contribute to the risk of prostate cancer, and perhaps also contribute to determining whether that cancer is of the more dangerous aggressive type.
The first aim of the proposal is to use human prostatic cells in culture to recapitulate the human data by manipulating MnSOD and GPx-1 genotype and levels, and determining the consequences to reactive oxygen species generation and damage to biomolecules under controlled experimental conditions. In the second aim, the effects of MnSOD and GPx-1 levels in promoting carcinogenesis will be investigated using human primary prostatic cells that will be engineered to over-express these proteins, allowed to form prostaspheres in 3D culture and implanted under the renal capsule of nude mice. These structures ultimately develop into tumors. Xenograft studies with human prostate tumor cells engineered to over-express different MnSOD and GPx-1 alleles injected into nude mice will also be conducted to evaluate the effect of these proteins on tumor growth. The same endpoints investigated in the first aim will be assessed in the mouse prostatic tissues.
The third aim i s to determine whether MnSOD genotype predicts risk of recurrence/progression in two independent case series of patients with clinically organ-confined prostate cancer, 400 cases from the Cooperative Prostate Cancer Tissue Resource (CPCTR) using a case vs. non-recurrent control study design and 200 cases from an ongoing NIH-supported prospective cohort study of lifestyle determinants of prognosis. The secondary goal is to explore the interaction of MnSOD genotype with GPx-1 and SEPP1 genotype and with antioxidant intake with respect to recurrence/progression risk. It is anticipated that the results f these studies will elucidate some of the important determinants of prostate cancer risk, allowing for better prediction as to whose prostate cancer will progress, and providing new targets for individualized preventive and therapeutic interventions.

Public Health Relevance

Human epidemiology has revealed a remarkable impact of dietary antioxidant intake, as well as polymorphisms in the gene for the GPx-1 anti-oxidant protein, in the risk of aggressive, clinically significant prostate cancer among carriers of a common allelic variant of the MnSOD gene. By studying the mechanism of this interaction in model systems and determining the predictive value of MnSOD allelic identity, novel approaches may be developed to reduce prostate cancer mortality.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA193497-02
Application #
9142297
Study Section
Integrative Nutrition and Metabolic Processes Study Section (INMP)
Program Officer
Okano, Paul
Project Start
2015-09-09
Project End
2018-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
098987217
City
Chicago
State
IL
Country
United States
Zip Code
60612
Ekoue, Dede N; Ansong, Emmanuel; Liu, Li et al. (2018) Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer. Prostate 78:279-288
Ekoue, Dede N; Bera, Soumen; Ansong, Emmanuel et al. (2017) Allele-specific interaction between glutathione peroxidase 1 and manganese superoxide dismutase affects the levels of Bcl-2, Sirt3 and E-cadherin. Free Radic Res 51:582-590
Ekoue, Dede N; He, Chenxia; Diamond, Alan M et al. (2017) Manganese superoxide dismutase and glutathione peroxidase-1 contribute to the rise and fall of mitochondrial reactive oxygen species which drive oncogenesis. Biochim Biophys Acta Bioenerg 1858:628-632
Vandenberg, L N; Prins, G S (2016) Clarity in the face of confusion: new studies tip the scales on bisphenol A (BPA). Andrology 4:561-4
Prins, Gail S (2016) The Endocrine Society Centennial: Hormones and Apoptosis in the Prostate Gland… Live and Let Die. Endocrinology 157:2197-200
Gladyshev, Vadim N; Arnér, Elias S; Berry, Marla J et al. (2016) Selenoprotein Gene Nomenclature. J Biol Chem 291:24036-24040